H. R. 7391
Introduced in House · February 20, 2026February 5, 2026
Mr. Bergman (for himself, Mr. Auchincloss, Mr. Moulton, Mr. Lynch, Mr. Smucker, Ms. Lois Frankel of Florida, Ms. Norton, Mr. Mann, Mr. Mrvan, Ms. Balint, Ms. Davids of Kansas, Ms. Maloy, Mr. Bresnahan, Mr. Cleaver, Ms. Ansari, Mr. Huizenga, Ms. McBride, Ms. Titus, Ms. Tlaib, Mr. Neguse, Mr. Crank, Ms. Lee of Nevada, Mr. Lucas, Mr. Larsen of Washington, and Mr. Cohen) introduced the following bill; which was referred to the Committee on Energy and Commerce
A BILL
To amend title III of the Public Health Service Act to ensure that Federally-qualified health centers are not required to pay more than the 340B ceiling price for covered outpatient drugs at the time of purchase.
Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,
SECTION 1. Short title.
This Act may be cited as the “Community Health Center Drug Pricing Protection Act”.